Evidence map›Paper›PMID 35154247›Full record

ArticleFrontiers in genetics2021

Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development.

Ortiz-López María Guadalupe, Sánchez-Pozos Katy, Aguirre-Alvarado Charmina, Pirkko Vihko, Menjivar Marta

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Ortiz-López María GuadalupeLaboratorio de Endocrinología Molecular, Research Division, Hospital Juárez de México, Mexico City, Mexico.
Sánchez-Pozos KatyLaboratorio de Endocrinología Molecular, Research Division, Hospital Juárez de México, Mexico City, Mexico.
Aguirre-Alvarado CharminaLaboratorio de Bioquímica Farmacológica, Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Pirkko VihkoDepartment of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
Menjivar MartaLaboratorio de Diabetes, Departamento de Biología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Hospital Juárez de México · MXInstituto Politécnico Nacional · MXUniversidad Nacional Autónoma de México · MXUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

46.XY5-alpha-reductase deficiencydihydrotestosteronetestosteroneundefined genitalia

Identifiers

PMID35154247
PMCPMC8829113
OpenAlexW4210315238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.